News & Press | AmbioPharm

Ambio Announces US FDA Approval of a Generic Version of Forteo® (Teriparatide Injection) for its partner Apotex

December 1, 2023

Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States (with exclusive co-development partner, Ambio, Inc.)

November 24, 2023

Adalvo announces successful launch of Icatibant in close collaboration with strategic partner Ambio

January 27, 2022

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services

Have a Peptide project?

SUBMIT YOUR REQUIREMENTS